We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+8.78%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$44.5B
AUM Growth
+$4.78B
(+12%)
Cap. Flow
+$1.4B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,352
New
50
Increased
563
Reduced
449
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$93.8M |
| 2 |
Abbott
ABT
|
+$80.1M |
| 3 |
Deere & Co
DE
|
+$77.3M |
| 4 |
Parker-Hannifin
PH
|
+$72.4M |
| 5 |
Emerson Electric
EMR
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$172M |
| 2 |
Broadcom
AVGO
|
+$58.8M |
| 3 |
UBS Group
UBS
|
+$53.1M |
| 4 |
Palo Alto Networks
PANW
|
+$51.1M |
| 5 |
Marvell Technology
MRVL
|
+$46.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.46% |
| 2 | Healthcare | 17.84% |
| 3 | Industrials | 10.35% |
| 4 | Financials | 10.06% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Teladoc Health
TDOC
$1.29B
| $1.78M | ﹤0.01% |
69,450
-5,550
| -7% | -$140K |
|
777
Madrigal Pharmaceuticals
MDGL
$11.9B
| $1.76M | ﹤0.01% |
8,000
+2,200
| +38% | +$596K |
|
778
Zai Lab
ZLAB
$2.65B
| $1.76M | ﹤0.01% |
66,648
+36,366
| +120% | +$1.19M |
|
779
Denali Therapeutics
DNLI
$4B
| $1.75M | ﹤0.01% |
59,800
| – | – |
|
780
Beam Therapeutics
BEAM
$2.82B
| $1.75M | ﹤0.01% |
55,000
| – | – |
|
781
NRG Energy
NRG
$25B
| $1.74M | ﹤0.01% |
46,272
-39,439
| -46% | -$1.34M |
|
782
Halozyme
HALO
$11.6B
| $1.74M | ﹤0.01% |
50,000
| – | – |
|
|
PARA
783
DELISTED
Paramount Global Class B
PARA
| $1.72M | ﹤0.01% |
105,060
-72,822
| -41% | -$1.32M |
|
784
Caesars Entertainment
CZR
$6.13B
| $1.71M | ﹤0.01% |
34,539
+8,935
| +35% | +$406K |
|
785
Lithia Motors
LAD
$8.35B
| $1.71M | ﹤0.01% |
5,620
| – | – |
|
786
10x Genomics
TXG
$7.63B
| $1.7M | ﹤0.01% |
30,000
| – | – |
|
787
BridgeBio Pharma
BBIO
$16.6B
| $1.7M | ﹤0.01% |
100,000
| – | – |
|
|
RETA
788
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.7M | ﹤0.01% |
17,000
| – | – |
|
789
CF Industries
CF
$18.4B
| $1.68M | ﹤0.01% |
24,017
-5,119
| -18% | -$357K |
|
|
SYNH
790
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.67M | ﹤0.01% |
40,000
| – | – |
|
791
EXL Service
EXLS
$5.32B
| $1.67M | ﹤0.01% |
55,290
+1,710
| +3% | +$53.9K |
|
|
BPMC
792
DELISTED
Blueprint Medicines
BPMC
| $1.66M | ﹤0.01% |
25,150
| – | – |
|
793
Ally Financial
ALLY
$13.3B
| $1.66M | ﹤0.01% |
62,259
-3,899
| -6% | -$104K |
|
794
Tapestry
TPR
$33.3B
| $1.65M | ﹤0.01% |
38,801
-21,560
| -36% | -$898K |
|
795
Fortune Brands Innovations
FBIN
$5.73B
| $1.65M | ﹤0.01% |
22,914
-2,177
| -9% | -$138K |
|
796
Guardant Health
GH
$22.4B
| $1.64M | ﹤0.01% |
45,000
-253,000
| -85% | -$7.27M |
|
797
Trupanion
TRUP
$1.27B
| $1.63M | ﹤0.01% |
+80,000
| New | +$2.26M |
|
798
Belden
BDC
$5.28B
| $1.63M | ﹤0.01% |
+17,055
| New | +$1.46M |
|
799
Comfort Systems
FIX
$58.9B
| $1.63M | ﹤0.01% |
+9,804
| New | +$1.46M |
|
800
Bio-Techne
TECH
$11.2B
| $1.62M | ﹤0.01% |
20,362
-10,223
| -33% | -$822K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2023 Portfolio in Review
As of Q2 2023, DekaBank Deutsche Girozentrale held 1,352 positions worth $44.5B, up 12% from $39.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
DekaBank Deutsche Girozentrale deployed $1.4B of net new capital in Q2 2023, opening 50 new positions and adding to 563 existing holdings. Its largest new stake was Kenvue: 335,150 shares worth $8.63M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was NVIDIA, an estimated $172M trimmed.
- DekaBank Deutsche Girozentrale's largest Q2 2023 buy was Kenvue: 335,150 shares worth $8.63M.
- DekaBank Deutsche Girozentrale added most to Procter & Gamble in Q2 2023, an estimated $93.8M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $172M.
- DekaBank Deutsche Girozentrale fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $19.8M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 24% of its $44.5B portfolio in Q2 2023.
- DekaBank Deutsche Girozentrale opened 50 new positions and closed 104 in Q2 2023.
- DekaBank Deutsche Girozentrale's portfolio value rose 12% quarter-over-quarter to $44.5B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.